- Home
- VSTE vs KRON Comparison
VSTE vs KRON Comparison
Compare VSTE & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- KRON
- Stock Information
- Founded
- VSTE 2009
- KRON 2017
- Country
- VSTE Australia
- KRON United States
- Employees
- VSTE N/A
- KRON N/A
- Industry
- VSTE
- KRON Medicinal Chemicals and Botanical Products
- Sector
- VSTE
- KRON Health Care
- Exchange
- VSTE Nasdaq
- KRON Nasdaq
- Market Cap
- VSTE 51.9M
- KRON 55.5M
- IPO Year
- VSTE N/A
- KRON 2020
- Fundamental
- Price
- VSTE $1.17
- KRON $0.94
- Analyst Decision
- VSTE
- KRON Buy
- Analyst Count
- VSTE 0
- KRON 3
- Target Price
- VSTE N/A
- KRON $1.63
- AVG Volume (30 Days)
- VSTE 3.7M
- KRON 425.0K
- Earning Date
- VSTE 01-01-0001
- KRON 11-13-2024
- Dividend Yield
- VSTE N/A
- KRON N/A
- EPS Growth
- VSTE N/A
- KRON N/A
- EPS
- VSTE N/A
- KRON N/A
- Revenue
- VSTE $342,000.00
- KRON $9,864,000.00
- Revenue This Year
- VSTE N/A
- KRON $62.21
- Revenue Next Year
- VSTE N/A
- KRON N/A
- P/E Ratio
- VSTE N/A
- KRON N/A
- Revenue Growth
- VSTE N/A
- KRON 146.48
- 52 Week Low
- VSTE $0.83
- KRON $0.69
- 52 Week High
- VSTE $11.99
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- VSTE 42.18
- KRON 48.11
- Support Level
- VSTE $1.12
- KRON $0.91
- Resistance Level
- VSTE $2.38
- KRON $0.96
- Average True Range (ATR)
- VSTE 0.22
- KRON 0.06
- MACD
- VSTE -0.02
- KRON -0.01
- Stochastic Oscillator
- VSTE 3.97
- KRON 24.92
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.